CDC174 Promotes Cancer Growth and Metastasis (G51244)

Target Name: CCDC174

NCBI ID: G51244

CCDC174

CDC174 Promotes Cancer Growth and Metastasis

CCDC174 (CTR1) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the carcinoembryonic antigen (CEA) family, which consists of proteins that are expressed in a wide variety of tissues and have been implicated in cancer progression.

One of the most significant aspects of CCDC174 is its role in cancer development is its ability to promote tumor growth and metastasis. CCDC174 has been shown to stimulate the growth of cancer cells in various models, including mouse models of breast, lung, and ovarian cancer. Additionally, it has been shown to promote the formation of new blood vessels in tumors, which can contribute to the development of metastasis.

Another important function of CCDC174 is its role in cancer immune surveillance. CCDC174 has been shown to interact with immune cells, including T cells and natural killer cells. This interaction may help to protect cancer cells from immune surveillance and may also contribute to the development of cancer immune evasion strategies.

CDC174 is also a potential drug target for several cancer types. For example, CCDC174 has been shown to be overexpressed in various types of cancer, including breast, lung, and ovarian cancer. Additionally, CCDC174 has been shown to interact with several anti-cancer drugs, including monoclonal antibodies and tyrosine kinase inhibitors. This suggests that CCDC174 may be a useful target for cancer treatment.

In conclusion, CCDC174 is a protein that has been shown to promote tumor growth and metastasis, as well as contribute to cancer immune surveillance. As a potential drug target, CCDC174 is a promising target for cancer treatment. Further research is needed to fully understand the role of CCDC174 in cancer development and to develop effective strategies for its targeting.

Protein Name: Coiled-coil Domain Containing 174

Functions: Probably involved in neuronal development

The "CCDC174 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC174 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets